REGISTERED COMPANY NUMBER: 06882020 (England and Wales) REGISTERED CHARITY NUMBER: 1133051
Report of the Trustees and
Unaudited Financial Statements for the Year Ended 31 March 2023
for
Beanibazar Cancer and General Hospital
Abacus Tax Consultants Ltd Chartered Accountants The Colmore Building 20 Colmore Circus Birmingham West Midlands B4 6AT
Beanibazar Cancer and General Hospital
Contents of the Financial Statements for the Year Ended 31 March 2023
| Page | |
|---|---|
| Report of the Trustees | 1 to 2 |
| Independent Examiner's Report | 3 |
| Statement of Financial Activities | 4 |
| Balance Sheet | 5 to 6 |
| Notes to the Financial Statements | 7 to 12 |
| Detailed Statement of Financial Activities | 13 to 14 |
Beanibazar Cancer and General Hospital
Report of the Trustees
for the Year Ended 31 March 2023
The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 March 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
OBJECTIVES AND ACTIVITIES Objectives and aims
The Charity's objects ('the Objects') are:
(1) To provide for the erection and maintenance of a fully resourced hospital in the area of Beani Bazar, Sylhet, Bangladesh for the purposes of diagnosis, prevention and cure of all forms of cancer.
(2) To provide information and raise public awareness of all such matters relating to cancer and healthcare.
(3) To protect and promote the health of the public in the UK and Bangladesh with particular regard to the disadvantaged people originating from and residing in Beani Bazar, Sylhet, Bangladesh and surrounding areas.
(4) To provide relief, support and assistance for people who suffer from or have suffered from any form of cancer and related illness.
(5) To further all other charitable pursuits as deemed appropriate by the trustees with particular regard to cancer care and treatment which includes starting outdoor campaign, chemotherapy treatment, medical camps etc.
FINANCIAL REVIEW
Total incoming resources in the year amounted to £225,315 (2022: £367,632) with a net deficit of £18,816(2022: £147,425 surplus ) at the year end.
FUTURE PLANS
(1) The charity is working hard to expand on its services at the hospital in Bangladesh by recruiting additional specialist doctors and starting the mobile clinic service. The mobile clinic service will be a mobile vehicle with medical equipment visiting local areas and providing cancer prevention advice and general medical services to those in need.
(2) We are also planning to expand the outreach work through medical camps and community health workers.
(3) The Trustees are planning to raise funds through further marketing and fundraising events to fund our activities.
(4) We are looking to further establish the general Patients Department, set up Paediatrics & expand the Maternity Ward.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006.
Page 1
Beanibazar Cancer and General Hospital
Report of the Trustees
for the Year Ended 31 March 2023
STRUCTURE, GOVERNANCE AND MANAGEMENT
Risk management
The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.
REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number
06882020 (England and Wales)
Registered Charity number
1133051
Registered office
74-76 Tower Bridge Road London SE1 4TP
Trustees
Shamsuddin Khan - Chairman M Shab Uddin - CEO Shalim Uddin - Finance Director Mohammed N Uddin
Independent Examiner
Monzur Sumon MA, FCCA, ACA, CTA Abacus Tax Consultants Ltd Chartered Accountants The Colmore Building 20 Colmore Circus Birmingham West Midlands B4 6AT
Approved by order of the board of trustees on 8 December 2023 and signed on its behalf by:
M Shab Uddin - Trustee
Page 2
Independent Examiner's Report to the Trustees of Beanibazar Cancer and General Hospital
Independent examiner's report to the trustees of Beanibazar Cancer and General Hospital ('the Company')
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2023.
Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
-
accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
-
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Monzur Sumon MA, FCCA, ACA, CTA
Abacus Tax Consultants Ltd Chartered Accountants The Colmore Building 20 Colmore Circus Birmingham West Midlands B4 6AT
8 December 2023
Page 3
Beanibazar Cancer and General Hospital
Statement of Financial Activities for the Year Ended 31 March 2023
| Notes INCOME AND ENDOWMENTS FROM Donations and legacies Investment income 2 Total EXPENDITURE ON Raising funds Charitable activities HOSPITAL Total NET INCOME/(EXPENDITURE) RECONCILIATION OF FUNDS Total funds brought forward TOTAL FUNDS CARRIED FORWARD |
31.3.23 31.3.22 Unrestricted Total fund funds £ £ 199,338 343,919 25,977 23,713 225,315 367,632 26,869 38,812 217,263 181,395 244,132 220,207 (18,817) 147,425 1,324,711 1,177,286 1,305,894 1,324,711 |
31.3.23 31.3.22 Unrestricted Total fund funds £ £ 199,338 343,919 25,977 23,713 225,315 367,632 26,869 38,812 217,263 181,395 244,132 220,207 (18,817) 147,425 1,324,711 1,177,286 1,305,894 1,324,711 |
|---|---|---|
| 367,632 | ||
| 38,812 181,395 |
||
| 220,207 | ||
| 147,425 1,177,286 |
||
| 1,324,711 |
The notes form part of these financial statements
Page 4
Beanibazar Cancer and General Hospital
Balance Sheet 31 March 2023
| Notes FIXED ASSETS Tangible assets 6 CURRENT ASSETS Cash at bank and in hand CREDITORS Amounts falling due within one year 7 NET CURRENT ASSETS TOTAL ASSETS LESS CURRENT LIABILITIES NET ASSETS FUNDS 8 Unrestricted funds TOTAL FUNDS |
31.3.23 31.3.22 Unrestricted Total fund funds £ £ 533,684 543,629 779,818 788,092 (7,608) (7,010) 772,210 781,082 1,305,894 1,324,711 1,305,894 1,324,711 1,305,894 1,324,711 1,305,894 1,324,711 |
|---|---|
The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
-
(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
-
(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
The notes form part of these financial statements
Page 5
continued...
Beanibazar Cancer and General Hospital
Balance Sheet - continued
31 March 2023
These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.
The financial statements were approved by the Board of Trustees and authorised for issue on 8 December 2023 and were signed on its behalf by:
M Shab Uddin - Trustee
The notes form part of these financial statements
Page 6
Beanibazar Cancer and General Hospital
Notes to the Financial Statements for the Year Ended 31 March 2023
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
| Plant and machinery | - 20% on reducing balance |
|---|---|
| Fixtures and fittings | - 20% on reducing balance |
| Motor vehicles | - 20% on reducing balance |
Taxation
The charity is exempt from corporation tax on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
Page 7
continued...
Beanibazar Cancer and General Hospital
Notes to the Financial Statements - continued for the Year Ended 31 March 2023
2. INVESTMENT INCOME
| Interest receivable 3. NET INCOME/(EXPENDITURE) Net income/(expenditure) is stated after charging/(crediting): Depreciation - owned assets |
31.3.23 £ 25,977 31.3.23 £ 9,945 |
31.3.22 £ 23,713 |
|---|---|---|
| 31.3.22 £ 12,433 |
4. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the year ended 31 March 2023 nor for the year ended 31 March 2022.
Trustees' expenses
There were no trustees' expenses paid for the year ended 31 March 2023 nor for the year ended 31 March 2022.
5. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
| INCOME AND ENDOWMENTS FROM Donations and legacies Investment income Total EXPENDITURE ON Raising funds Charitable activities HOSPITAL Total NET INCOME RECONCILIATION OF FUNDS Total funds brought forward |
Unrestricted fund £ 343,919 23,713 367,632 38,812 181,395 220,207 147,425 1,177,286 |
|---|---|
Page 8
continued...
Beanibazar Cancer and General Hospital
Notes to the Financial Statements - continued for the Year Ended 31 March 2023
| 5. | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued |
|---|---|---|---|---|
| Unrestricted | ||||
| fund | ||||
| £ | ||||
| TOTAL FUNDS CARRIED | ||||
| FORWARD | 1,324,711 | |||
| 6. | TANGIBLE FIXED ASSETS | |||
| Fixtures | ||||
| Freehold | Plant and | and | ||
| property | machinery | fittings | ||
| £ | £ | £ | ||
| COST | ||||
| At 1 April 2022 and 31 March 2023 | 493,900 | 162,084 | 30,361 | |
| DEPRECIATION | ||||
| At 1 April 2022 | - | 124,455 | 22,540 | |
| Charge for year | - | 7,526 | 1,564 | |
| At 31 March 2023 | - | 131,981 | 24,104 | |
| NET BOOK VALUE | ||||
| At 31 March 2023 | 493,900 | 30,103 | 6,257 | |
| At 31 March 2022 | 493,900 | 37,629 | 7,821 | |
| Motor | Computer | |||
| vehicles | equipment | Totals | ||
| £ | £ | £ | ||
| COST | ||||
| At 1 April 2022 and 31 March 2023 | 14,400 | 714 | 701,459 | |
| DEPRECIATION | ||||
| At 1 April 2022 | 10,578 | 257 | 157,830 | |
| Charge for year | 764 | 91 | 9,945 | |
| At 31 March 2023 | 11,342 | 348 | 167,775 | |
| NET BOOK VALUE | ||||
| At 31 March 2023 | 3,058 | 366 | 533,684 | |
| At 31 March 2022 | 3,822 | 457 | 543,629 |
Page 9
continued...
Beanibazar Cancer and General Hospital
| Notes to the Financial Statements-continued for the Year Ended 31 March 2023 7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Trade creditors Social security and other taxes Other creditors 8. MOVEMENT IN FUNDS At 1.4.22 £ Unrestricted funds General fund 1,324,711 TOTAL FUNDS 1,324,711 Net movement in funds, included in the above are as follows: Incoming resources £ Unrestricted funds General fund 225,315 TOTAL FUNDS 225,315 Comparatives for movement in funds At 1.4.21 £ Unrestricted funds General fund 1,177,286 TOTAL FUNDS 1,177,286 |
31.3.23 31.3.22 £ £ 1,740 1,593 1,908 1,193 3,960 4,224 7,608 7,010 Net movement At in funds 31.3.23 £ £ (18,817) 1,305,894 (18,817) 1,305,894 Resources Movement expended in funds £ £ (244,132) (18,817) (244,132) (18,817) Net movement At in funds 31.3.22 £ £ 147,425 1,324,711 147,425 1,324,711 |
|
|---|---|---|
Page 10
continued...
Beanibazar Cancer and General Hospital
Notes to the Financial Statements - continued for the Year Ended 31 March 2023
8. MOVEMENT IN FUNDS - continued
Comparative net movement in funds, included in the above are as follows:
| Incoming | Resources | Movement | |
|---|---|---|---|
| resources | expended | in funds | |
| £ | £ | £ | |
| Unrestricted funds | |||
| General fund | 367,632 | (220,207) | 147,425 |
| TOTAL FUNDS | 367,632 | (220,207) | 147,425 |
| A current year 12 months and prior year 12 months combined position is as follows: | |||
| Net | |||
| movement | At | ||
| At 1.4.21 | in funds | 31.3.23 | |
| £ | £ | £ | |
| Unrestricted funds | |||
| General fund | 1,177,286 | 128,608 | 1,305,894 |
| TOTAL FUNDS | 1,177,286 | 128,608 | 1,305,894 |
| A current year 12 months and prior year | 12 months combined | net movement in fund | |
| included in the above are as follows: | |||
| Incoming | Resources | Movement | |
| resources | expended | in funds | |
| £ | £ | £ | |
| Unrestricted funds | |||
| General fund | 592,947 | (464,339) | 128,608 |
| TOTAL FUNDS | 592,947 | (464,339) | 128,608 |
A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:
Page 11
continued...
Beanibazar Cancer and General Hospital
Notes to the Financial Statements - continued for the Year Ended 31 March 2023
9. RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 31 March 2023.
Page 12
| Beanibazar Cancer and General Hospital Detailed Statement of Financial Activities for the Year Ended 31 March 2023 INCOME AND ENDOWMENTS Donations and legacies Donations Grants Investment income Interest receivable Total incoming resources EXPENDITURE Other trading activities Purchases Charitable activities Wages Insurance Telephone Sundries Room Hire Rent Light and Heat Repairs and maintenance Stationery and Printing Household and Cleaning Travel and Subsistence Penalty Motor Vehicle Expenses Subscriptions Software Food & Refreshment Equipment Hire Advertising Equipment expensed Exchange gain/loss Temp & Recruitment Other Legal and Professional |
31.3.23 £ 199,338 - 199,338 25,977 225,315 26,869 66,844 547 1,897 1,138 14,460 6,834 3,026 5,083 974 1,059 2,360 - 8,863 2,448 2,549 1,825 3,119 16,324 3,559 28,902 5,883 23,425 201,119 |
31.3.22 £ 343,236 683 343,919 23,713 367,632 38,812 63,257 496 1,323 916 1,500 11,187 3,361 2,161 984 769 2,009 100 3,872 (554) 4,941 720 2,620 64,924 3,512 (11,310) 6,518 860 164,166 |
|---|---|---|
This page does not form part of the statutory financial statements
Page 13
Beanibazar Cancer and General Hospital
| Detailed Statement of Financial Activities for the Year Ended 31 March 2023 Support costs Management Social security Finance Depreciation of tangible fixed assets Governance costs Accountancy and legal fees Bank Charges Total resources expended Net (expenditure)/income |
31.3.23 £ 1,132 9,946 3,000 2,066 5,066 244,132 (18,817) |
31.3.22 £ 837 12,432 3,302 658 |
|---|---|---|
| 3,960 | ||
| 220,207 | ||
| 147,425 |
This page does not form part of the statutory financial statements
Page 14